Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of NeuroAiD II™ (MLC901) to Improve Cognitive Functioning in Non-surgical Mild Traumatic Brain Injury Patients

NCT04861688 is registered in ClinicalTrials.gov with Moleac Pte Ltd. as lead sponsor.

NCT NCT04861688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04861688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of NeuroAiD II™ (MLC901) to Improve Cognitive Functioning in Non-surgical Mild Traumatic Brain Injury Patients
Lead sponsor
Moleac Pte Ltd.
Phase
Phase 3
Overall status
Completed
Start date
August 23, 2021
Completion date
February 14, 2023
Enrollment
182 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury